Development and Validation of Stability Indicating Method for Simultaneous Estimation of Famotidine and Domperidone in Bulk and Tablet Dosage Forms Using RP-HPLC Article Swipe

PDF

Subhahan B.S , M. Mahesh , Kiran Joythi R , Satish Babu Rajulapati ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.30904/j.ijcps.2025.4784

A novel, precise, and accurate Reverse Phase-High Performance Liquid Chromatography (RP- HPLC) method was developed and validated for the simultaneous estimation of Famotidine (FAM) and Domperidone (DOM) in bulk and tablet dosage forms. The method was optimized using a Symmetry C18 column (250 mm × 4.6 mm, 5 µm) with a mobile phase consisting of 0.002 M Sodium dihydrogen phosphate buffer (pH 5.8) and acetonitrile (60:40, v/v) at a flow rate of 1 mL/min. Detection was performed at 287 nm using a Photo Diode Array (PDA) detector. The retention times for FAM and DOM were 3.216 min and 5.762 min, respectively, with a resolution of 10.10. The method demonstrated linearity in the range of 5-30 µg/mL for FAM and 2.5-15 µg/mL for DOM, with correlation coefficients r2 of 0.999 for both drugs. The method was validated as per ICH guidelines, showing excellent accuracy (recovery 99.45%-99.73% for FAM and 99.33%-100% for DOM), precision (RSD < 2%), and robustness. Forced degradation studies under acid, alkali, oxidative, thermal, and photolytic conditions confirmed the stability-indicating nature of the method. FAM was more sensitive to alkali hydrolysis, while DOM showed sensitivity to both acid and alkali hydrolysis. The method was successfully applied to the analysis of commercial tablet formulations, with no interference from excipients. The developed RP-HPLC method is simple, rapid, and reliable, making it suitable for routine quality control and stability studies of FAM and DOM in combined dosage forms.

Related Topics

High-Performance Liquid Chromatography

Concepts

Famotidine Domperidone Dosage form Chromatography High-performance liquid chromatography Chemistry Mathematics Pharmacology Medicine Internal medicine Dopamine

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.30904/j.ijcps.2025.4784
PDF: https://pharmaresearchlibrary.org/journals/index.php/ijcps/article/download/78/82
OA Status: hybrid
Related Works: 10
OpenAlex ID: https://openalex.org/W4411207091

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4411207091

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.30904/j.ijcps.2025.4784

Digital Object Identifier
Title: Development and Validation of Stability Indicating Method for Simultaneous Estimation of Famotidine and Domperidone in Bulk and Tablet Dosage Forms Using RP-HPLC

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-04-20

Full publication date if available
Authors: Subhahan B.S, M. Mahesh, Kiran Joythi R, Satish Babu Rajulapati

List of authors in order
Landing page: https://doi.org/10.30904/j.ijcps.2025.4784

Publisher landing page
PDF URL: https://pharmaresearchlibrary.org/journals/index.php/ijcps/article/download/78/82

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: hybrid

Open access status per OpenAlex
OA URL: https://pharmaresearchlibrary.org/journals/index.php/ijcps/article/download/78/82

Direct OA link when available
Concepts: Famotidine, Domperidone, Dosage form, Chromatography, High-performance liquid chromatography, Chemistry, Mathematics, Pharmacology, Medicine, Internal medicine, Dopamine

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4411207091
doi	https://doi.org/10.30904/j.ijcps.2025.4784
ids.doi	https://doi.org/10.30904/j.ijcps.2025.4784
ids.openalex	https://openalex.org/W4411207091
fwci	0.0
type	article
title	Development and Validation of Stability Indicating Method for Simultaneous Estimation of Famotidine and Domperidone in Bulk and Tablet Dosage Forms Using RP-HPLC
biblio.issue	1
biblio.volume	13
biblio.last_page	15
biblio.first_page	09
topics[0].id	https://openalex.org/T11460
topics[0].field.id	https://openalex.org/fields/16
topics[0].field.display_name	Chemistry
topics[0].score	0.9991999864578247
topics[0].domain.id	https://openalex.org/domains/3
topics[0].domain.display_name	Physical Sciences
topics[0].subfield.id	https://openalex.org/subfields/1602
topics[0].subfield.display_name	Analytical Chemistry
topics[0].display_name	Analytical Methods in Pharmaceuticals
topics[1].id	https://openalex.org/T11036
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9053999781608582
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2736
topics[1].subfield.display_name	Pharmacology
topics[1].display_name	Antibiotics Pharmacokinetics and Efficacy
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2781263782
concepts[0].level	2
concepts[0].score	0.9458324909210205
concepts[0].wikidata	https://www.wikidata.org/wiki/Q411159
concepts[0].display_name	Famotidine
concepts[1].id	https://openalex.org/C2775995038
concepts[1].level	3
concepts[1].score	0.9325169324874878
concepts[1].wikidata	https://www.wikidata.org/wiki/Q424238
concepts[1].display_name	Domperidone
concepts[2].id	https://openalex.org/C77281830
concepts[2].level	2
concepts[2].score	0.776383101940155
concepts[2].wikidata	https://www.wikidata.org/wiki/Q718608
concepts[2].display_name	Dosage form
concepts[3].id	https://openalex.org/C43617362
concepts[3].level	1
concepts[3].score	0.666874885559082
concepts[3].wikidata	https://www.wikidata.org/wiki/Q170050
concepts[3].display_name	Chromatography
concepts[4].id	https://openalex.org/C179998833
concepts[4].level	2
concepts[4].score	0.49724748730659485
concepts[4].wikidata	https://www.wikidata.org/wiki/Q381233
concepts[4].display_name	High-performance liquid chromatography
concepts[5].id	https://openalex.org/C185592680
concepts[5].level	0
concepts[5].score	0.41009652614593506
concepts[5].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[5].display_name	Chemistry
concepts[6].id	https://openalex.org/C33923547
concepts[6].level	0
concepts[6].score	0.34659940004348755
concepts[6].wikidata	https://www.wikidata.org/wiki/Q395
concepts[6].display_name	Mathematics
concepts[7].id	https://openalex.org/C98274493
concepts[7].level	1
concepts[7].score	0.21427109837532043
concepts[7].wikidata	https://www.wikidata.org/wiki/Q128406
concepts[7].display_name	Pharmacology
concepts[8].id	https://openalex.org/C71924100
concepts[8].level	0
concepts[8].score	0.15111929178237915
concepts[8].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[8].display_name	Medicine
concepts[9].id	https://openalex.org/C126322002
concepts[9].level	1
concepts[9].score	0.07443627715110779
concepts[9].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[9].display_name	Internal medicine
concepts[10].id	https://openalex.org/C513476851
concepts[10].level	2
concepts[10].score	0.0
concepts[10].wikidata	https://www.wikidata.org/wiki/Q170304
concepts[10].display_name	Dopamine
keywords[0].id	https://openalex.org/keywords/famotidine
keywords[0].score	0.9458324909210205
keywords[0].display_name	Famotidine
keywords[1].id	https://openalex.org/keywords/domperidone
keywords[1].score	0.9325169324874878
keywords[1].display_name	Domperidone
keywords[2].id	https://openalex.org/keywords/dosage-form
keywords[2].score	0.776383101940155
keywords[2].display_name	Dosage form
keywords[3].id	https://openalex.org/keywords/chromatography
keywords[3].score	0.666874885559082
keywords[3].display_name	Chromatography
keywords[4].id	https://openalex.org/keywords/high-performance-liquid-chromatography
keywords[4].score	0.49724748730659485
keywords[4].display_name	High-performance liquid chromatography
keywords[5].id	https://openalex.org/keywords/chemistry
keywords[5].score	0.41009652614593506
keywords[5].display_name	Chemistry
keywords[6].id	https://openalex.org/keywords/mathematics
keywords[6].score	0.34659940004348755
keywords[6].display_name	Mathematics
keywords[7].id	https://openalex.org/keywords/pharmacology
keywords[7].score	0.21427109837532043
keywords[7].display_name	Pharmacology
keywords[8].id	https://openalex.org/keywords/medicine
keywords[8].score	0.15111929178237915
keywords[8].display_name	Medicine
keywords[9].id	https://openalex.org/keywords/internal-medicine
keywords[9].score	0.07443627715110779
keywords[9].display_name	Internal medicine
language	en
locations[0].id	doi:10.30904/j.ijcps.2025.4784
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S5406990715
locations[0].source.issn	2321-3132
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	2321-3132
locations[0].source.is_core	False
locations[0].source.is_in_doaj	False
locations[0].source.display_name	International Journal of Chemistry and Pharmaceutical Sciences
locations[0].source.host_organization
locations[0].source.host_organization_name
locations[0].license	cc-by-nc
locations[0].pdf_url	https://pharmaresearchlibrary.org/journals/index.php/ijcps/article/download/78/82
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	International Journal of Chemistry and Pharmaceutical Sciences
locations[0].landing_page_url	https://doi.org/10.30904/j.ijcps.2025.4784
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5118476070
authorships[0].author.orcid
authorships[0].author.display_name	Subhahan B.S
authorships[0].author_position	first
authorships[0].raw_author_name	Subhahan B.S
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5111480546
authorships[1].author.orcid	https://orcid.org/0009-0001-5881-6606
authorships[1].author.display_name	M. Mahesh
authorships[1].author_position	middle
authorships[1].raw_author_name	Mahesh M
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5017868477
authorships[2].author.orcid
authorships[2].author.display_name	Kiran Joythi R
authorships[2].author_position	middle
authorships[2].raw_author_name	Kiran Joythi R
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5014841490
authorships[3].author.orcid	https://orcid.org/0000-0002-3812-8347
authorships[3].author.display_name	Satish Babu Rajulapati
authorships[3].author_position	last
authorships[3].raw_author_name	Shyam Raj Naik B.R
authorships[3].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://pharmaresearchlibrary.org/journals/index.php/ijcps/article/download/78/82
open_access.oa_status	hybrid
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Development and Validation of Stability Indicating Method for Simultaneous Estimation of Famotidine and Domperidone in Bulk and Tablet Dosage Forms Using RP-HPLC
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11460
primary_topic.field.id	https://openalex.org/fields/16
primary_topic.field.display_name	Chemistry
primary_topic.score	0.9991999864578247
primary_topic.domain.id	https://openalex.org/domains/3
primary_topic.domain.display_name	Physical Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1602
primary_topic.subfield.display_name	Analytical Chemistry
primary_topic.display_name	Analytical Methods in Pharmaceuticals
related_works	https://openalex.org/W2370834623, https://openalex.org/W2581337614, https://openalex.org/W2075466941, https://openalex.org/W4367400045, https://openalex.org/W2287290619, https://openalex.org/W2263066702, https://openalex.org/W2026391790, https://openalex.org/W4386441827, https://openalex.org/W2791790299, https://openalex.org/W2979530064
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.30904/j.ijcps.2025.4784
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S5406990715
best_oa_location.source.issn	2321-3132
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	2321-3132
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	International Journal of Chemistry and Pharmaceutical Sciences
best_oa_location.source.host_organization
best_oa_location.source.host_organization_name
best_oa_location.license	cc-by-nc
best_oa_location.pdf_url	https://pharmaresearchlibrary.org/journals/index.php/ijcps/article/download/78/82
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	International Journal of Chemistry and Pharmaceutical Sciences
best_oa_location.landing_page_url	https://doi.org/10.30904/j.ijcps.2025.4784
primary_location.id	doi:10.30904/j.ijcps.2025.4784
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S5406990715
primary_location.source.issn	2321-3132
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	2321-3132
primary_location.source.is_core	False
primary_location.source.is_in_doaj	False
primary_location.source.display_name	International Journal of Chemistry and Pharmaceutical Sciences
primary_location.source.host_organization
primary_location.source.host_organization_name
primary_location.license	cc-by-nc
primary_location.pdf_url	https://pharmaresearchlibrary.org/journals/index.php/ijcps/article/download/78/82
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	International Journal of Chemistry and Pharmaceutical Sciences
primary_location.landing_page_url	https://doi.org/10.30904/j.ijcps.2025.4784
publication_date	2025-04-20
publication_year	2025
referenced_works_count	0
abstract_inverted_index.1	72
abstract_inverted_index.5	47
abstract_inverted_index.A	0
abstract_inverted_index.M	56
abstract_inverted_index.a	38, 50, 68, 81, 102
abstract_inverted_index.as	136
abstract_inverted_index.at	67, 77
abstract_inverted_index.in	27, 110, 232
abstract_inverted_index.is	213
abstract_inverted_index.it	219
abstract_inverted_index.mm	43
abstract_inverted_index.nm	79
abstract_inverted_index.no	205
abstract_inverted_index.of	21, 54, 71, 104, 113, 127, 172, 200, 228
abstract_inverted_index.r2	126
abstract_inverted_index.to	179, 186, 197
abstract_inverted_index.×	44
abstract_inverted_index.(pH	61
abstract_inverted_index.287	78
abstract_inverted_index.4.6	45
abstract_inverted_index.C18	40
abstract_inverted_index.DOM	93, 183, 231
abstract_inverted_index.FAM	91, 117, 146, 175, 229
abstract_inverted_index.ICH	138
abstract_inverted_index.The	33, 87, 106, 132, 192, 209
abstract_inverted_index.and	3, 15, 24, 29, 63, 92, 97, 118, 147, 155, 165, 189, 216, 225, 230
abstract_inverted_index.for	17, 90, 116, 121, 129, 145, 149, 221
abstract_inverted_index.min	96
abstract_inverted_index.mm,	46
abstract_inverted_index.per	137
abstract_inverted_index.the	18, 111, 169, 173, 198
abstract_inverted_index.was	13, 35, 75, 134, 176, 194
abstract_inverted_index.<	153
abstract_inverted_index.(250	42
abstract_inverted_index.(RP-	10
abstract_inverted_index.(RSD	152
abstract_inverted_index.2%),	154
abstract_inverted_index.5-30	114
abstract_inverted_index.5.8)	62
abstract_inverted_index.DOM,	122
abstract_inverted_index.acid	188
abstract_inverted_index.both	130, 187
abstract_inverted_index.bulk	28
abstract_inverted_index.flow	69
abstract_inverted_index.from	207
abstract_inverted_index.min,	99
abstract_inverted_index.more	177
abstract_inverted_index.rate	70
abstract_inverted_index.v/v)	66
abstract_inverted_index.were	94
abstract_inverted_index.with	49, 101, 123, 204
abstract_inverted_index.µm)	48
abstract_inverted_index.(DOM)	26
abstract_inverted_index.(FAM)	23
abstract_inverted_index.(PDA)	85
abstract_inverted_index.0.002	55
abstract_inverted_index.0.999	128
abstract_inverted_index.3.216	95
abstract_inverted_index.5.762	98
abstract_inverted_index.Array	84
abstract_inverted_index.DOM),	150
abstract_inverted_index.Diode	83
abstract_inverted_index.HPLC)	11
abstract_inverted_index.Photo	82
abstract_inverted_index.acid,	161
abstract_inverted_index.phase	52
abstract_inverted_index.range	112
abstract_inverted_index.times	89
abstract_inverted_index.under	160
abstract_inverted_index.using	37, 80
abstract_inverted_index.while	182
abstract_inverted_index.10.10.	105
abstract_inverted_index.2.5-15	119
abstract_inverted_index.Forced	157
abstract_inverted_index.Liquid	8
abstract_inverted_index.Sodium	57
abstract_inverted_index.alkali	180, 190
abstract_inverted_index.buffer	60
abstract_inverted_index.column	41
abstract_inverted_index.dosage	31, 234
abstract_inverted_index.drugs.	131
abstract_inverted_index.forms.	32, 235
abstract_inverted_index.making	218
abstract_inverted_index.method	12, 34, 107, 133, 193, 212
abstract_inverted_index.mobile	51
abstract_inverted_index.nature	171
abstract_inverted_index.novel,	1
abstract_inverted_index.rapid,	215
abstract_inverted_index.showed	184
abstract_inverted_index.tablet	30, 202
abstract_inverted_index.µg/mL	115, 120
abstract_inverted_index.(60:40,	65
abstract_inverted_index.RP-HPLC	211
abstract_inverted_index.Reverse	5
abstract_inverted_index.alkali,	162
abstract_inverted_index.applied	196
abstract_inverted_index.control	224
abstract_inverted_index.mL/min.	73
abstract_inverted_index.method.	174
abstract_inverted_index.quality	223
abstract_inverted_index.routine	222
abstract_inverted_index.showing	140
abstract_inverted_index.simple,	214
abstract_inverted_index.studies	159, 227
abstract_inverted_index.Symmetry	39
abstract_inverted_index.accuracy	142
abstract_inverted_index.accurate	4
abstract_inverted_index.analysis	199
abstract_inverted_index.combined	233
abstract_inverted_index.precise,	2
abstract_inverted_index.suitable	220
abstract_inverted_index.thermal,	164
abstract_inverted_index.(recovery	143
abstract_inverted_index.Detection	74
abstract_inverted_index.confirmed	168
abstract_inverted_index.detector.	86
abstract_inverted_index.developed	14, 210
abstract_inverted_index.excellent	141
abstract_inverted_index.linearity	109
abstract_inverted_index.optimized	36
abstract_inverted_index.performed	76
abstract_inverted_index.phosphate	59
abstract_inverted_index.precision	151
abstract_inverted_index.reliable,	217
abstract_inverted_index.retention	88
abstract_inverted_index.sensitive	178
abstract_inverted_index.stability	226
abstract_inverted_index.validated	16, 135
abstract_inverted_index.Famotidine	22
abstract_inverted_index.Phase-High	6
abstract_inverted_index.commercial	201
abstract_inverted_index.conditions	167
abstract_inverted_index.consisting	53
abstract_inverted_index.dihydrogen	58
abstract_inverted_index.estimation	20
abstract_inverted_index.oxidative,	163
abstract_inverted_index.photolytic	166
abstract_inverted_index.resolution	103
abstract_inverted_index.99.33%-100%	148
abstract_inverted_index.Domperidone	25
abstract_inverted_index.Performance	7
abstract_inverted_index.correlation	124
abstract_inverted_index.degradation	158
abstract_inverted_index.excipients.	208
abstract_inverted_index.guidelines,	139
abstract_inverted_index.hydrolysis,	181
abstract_inverted_index.hydrolysis.	191
abstract_inverted_index.robustness.	156
abstract_inverted_index.sensitivity	185
abstract_inverted_index.acetonitrile	64
abstract_inverted_index.coefficients	125
abstract_inverted_index.demonstrated	108
abstract_inverted_index.interference	206
abstract_inverted_index.simultaneous	19
abstract_inverted_index.successfully	195
abstract_inverted_index.99.45%-99.73%	144
abstract_inverted_index.formulations,	203
abstract_inverted_index.respectively,	100
abstract_inverted_index.Chromatography	9
abstract_inverted_index.stability-indicating	170
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	4
citation_normalized_percentile.value	0.2518216
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False